{"id":"simvastatin-20mg","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Simvastatin 20mg","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:36:42.225461+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:36:49.132718+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Simvastatin 20mg","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:36:50.080484+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201391/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:36:50.568190+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-27T23:37:43.682Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:36:52.735852+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07392541","phase":"PHASE1, PHASE2","title":"Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2026-01-30","conditions":"Advanced Biliary Tract Carcinoma","enrollment":29},{"nctId":"NCT07389304","phase":"PHASE1","title":"[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Lipid Profile,Blood Pressure","enrollment":100},{"nctId":"NCT07378293","phase":"PHASE1","title":"Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Diabete Mellitus, Lipid Profile","enrollment":100},{"nctId":"NCT03654053","phase":"PHASE3","title":"Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2020-10-02","conditions":"Cirrhosis","enrollment":142},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT05963568","phase":"PHASE3","title":"Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)","status":"NOT_YET_RECRUITING","sponsor":"Northern California Institute of Research and Education","startDate":"2026-01-01","conditions":"Stroke, Medication Adherence","enrollment":680},{"nctId":"NCT05821556","phase":"PHASE2","title":"Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients","status":"RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2023-06-12","conditions":"Adenocarcinoma of the Pancreas","enrollment":240},{"nctId":"NCT06431919","phase":"NA","title":"Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2025-06-10","conditions":"Decompensated Cirrhosis, Cirrhotic Cardiomyopathy, Cirrhosis, Liver","enrollment":260},{"nctId":"NCT03127631","phase":"NA","title":"A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients","status":"RECRUITING","sponsor":"McMaster University","startDate":"2015-10-21","conditions":"Prostate Cancer, Cardiovascular Disease","enrollment":6000},{"nctId":"NCT01602029","phase":"PHASE2","title":"Randomized Double Blind Placebo Control Study in Patients with Schizophrenia","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2010-08","conditions":"Schizophrenia, Schizoaffective Disorder, Psychosis Not Otherwise Specified","enrollment":303},{"nctId":"NCT05397405","phase":"NA","title":"Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-05-23","conditions":"Intracranial Artery Stenosis","enrollment":180},{"nctId":"NCT05059626","phase":"PHASE4","title":"Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee","status":"RECRUITING","sponsor":"Penn State University","startDate":"2023-12-01","conditions":"Endometriosis","enrollment":28},{"nctId":"NCT00541697","phase":"PHASE3","title":"Eze/Simva Switch Study in Diabetics (0653A-807)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-01-19","conditions":"Diabetes Mellitus, Type 2","enrollment":648},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04973800","phase":"NA","title":"Simvastatin and Emotional Processing (OxSTEP)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-07-05","conditions":"Depression, Inflammation","enrollment":101},{"nctId":"NCT00157924","phase":"PHASE4","title":"Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11","conditions":"Hypercholesterolemia","enrollment":190},{"nctId":"NCT00739050","phase":"PHASE4","title":"Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-09-19","conditions":"Systemic Lupus Erythematosus","enrollment":4},{"nctId":"NCT00442897","phase":"PHASE4","title":"Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Hypercholesterolemia","enrollment":229},{"nctId":"NCT00409773","phase":"PHASE3","title":"Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-01","conditions":"Hypercholesterolemia, Metabolic Syndrome","enrollment":1143},{"nctId":"NCT00479713","phase":"PHASE3","title":"A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-01","conditions":"Hypercholesterolemia","enrollment":618},{"nctId":"NCT00271817","phase":"PHASE3","title":"To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-12","conditions":"Hypercholesterolemia","enrollment":1220},{"nctId":"NCT00988364","phase":"PHASE4","title":"Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2007-03","conditions":"Metabolic Syndrome","enrollment":30},{"nctId":"NCT05511766","phase":"PHASE2, PHASE3","title":"Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2022-11-15","conditions":"Cirrhosis, Hepatic Encephalopathy, Ascites","enrollment":150},{"nctId":"NCT02188121","phase":"PHASE4","title":"Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2015-02","conditions":"Serious Mental Illness, Schizophrenia, Schizoaffective Disorder","enrollment":227},{"nctId":"NCT05682911","phase":"EARLY_PHASE1","title":"Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients","status":"COMPLETED","sponsor":"Jinnah Sindh Medical University","startDate":"2018-01-01","conditions":"The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients","enrollment":40},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":1000},{"nctId":"NCT02850081","phase":"PHASE3","title":"Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-06-01","conditions":"Carotid Artery Stenosis, Strokes","enrollment":31},{"nctId":"NCT04652089","phase":"PHASE1, PHASE2","title":"7-day Simvastatin and Emotional Processing","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-12-03","conditions":"Depression, Inflammation","enrollment":53},{"nctId":"NCT03775070","phase":"PHASE2","title":"Simvastatin Therapy in Patients With Dilated Cardiomyopathy.","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2019-01-17","conditions":"Dilated Cardiomyopathy","enrollment":8},{"nctId":"NCT03571802","phase":"PHASE4","title":"Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG)","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2018-06-13","conditions":"Obesity, Hyperlipidemias","enrollment":10},{"nctId":"NCT01587235","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-03","conditions":"Dyslipidemia","enrollment":""},{"nctId":"NCT00652444","phase":"PHASE4","title":"Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09","conditions":"Hypercholesterolemia","enrollment":120},{"nctId":"NCT00651014","phase":"PHASE4","title":"Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2004-01","conditions":"Hypercholesterolemia, Atherosclerosis","enrollment":82},{"nctId":"NCT05133310","phase":"PHASE4","title":"Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia","status":"UNKNOWN","sponsor":"Hospital General de Mexico","startDate":"2021-11-19","conditions":"Strains, Acute Lymphoblastic Leukemia, Sepsis","enrollment":108},{"nctId":"NCT04985201","phase":"PHASE2","title":"Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy","status":"UNKNOWN","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2021-11-01","conditions":"Small Cell Lung Cancer","enrollment":40},{"nctId":"NCT04698941","phase":"PHASE2","title":"Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy","status":"UNKNOWN","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2021-07-25","conditions":"Small Cell Lung Cancer","enrollment":40},{"nctId":"NCT03355027","phase":"NA","title":"Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease","status":"UNKNOWN","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-11-30","conditions":"Atherosclerosis, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT04829149","phase":"","title":"Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2016-06-14","conditions":"Dyslipidemias","enrollment":5717},{"nctId":"NCT00746603","phase":"NA","title":"Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors","status":"TERMINATED","sponsor":"Columbia University","startDate":"2008-01","conditions":"Carotid Artery Disease","enrollment":3},{"nctId":"NCT04301336","phase":"PHASE2, PHASE3","title":"Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2019-11-01","conditions":"Vaso-occlusive Crisis, Sickle Cell Disease, Sickle Cell Anemia in Children","enrollment":350},{"nctId":"NCT00477204","phase":"PHASE2","title":"Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Type 1 Diabetes Mellitus, Dyslipidemia","enrollment":9},{"nctId":"NCT02399709","phase":"PHASE2","title":"Trial to Evaluate the Efficacy of Simvastatin for Smoking Cessation","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2015-04-01","conditions":"Smoking Cessation","enrollment":124},{"nctId":"NCT03971019","phase":"PHASE3","title":"Survival Benefits of Statins in Breast Cancer Patients","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-03-28","conditions":"Breast Cancer Female","enrollment":314},{"nctId":"NCT00929955","phase":"PHASE1","title":"Role of Anti-Inflammatory Agents in Patients With Schizophrenia","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2009-06","conditions":"Schizophrenia, Schizoaffective Disorder, Psychosis Not Otherwise Specified","enrollment":36},{"nctId":"NCT02072161","phase":"PHASE2","title":"Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy","status":"COMPLETED","sponsor":"Esperion Therapeutics, Inc.","startDate":"2014-03","conditions":"Hypercholesterolemia","enrollment":133},{"nctId":"NCT00479882","phase":"PHASE3","title":"MK-0524B Lipid Study (MK-0524B-063)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-06-15","conditions":"Primary Hypercholesterolemia, Mixed Dyslipidemia","enrollment":2414},{"nctId":"NCT03375580","phase":"NA","title":"Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Guangdong Pharmaceutical University","startDate":"2017-12-31","conditions":"Nonalcoholic Fatty Liver Disease","enrollment":196},{"nctId":"NCT03329118","phase":"PHASE1","title":"Drug-drug Interaction Between Simvastatin and SHR3824","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2017-11-24","conditions":"Type 2 Diabetes","enrollment":12},{"nctId":"NCT00125060","phase":"NA","title":"Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2000-08","conditions":"Heart Diseases","enrollment":72},{"nctId":"NCT01299597","phase":"PHASE1","title":"A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-01-18","conditions":"Sleep Disorders","enrollment":30},{"nctId":"NCT02360826","phase":"PHASE1","title":"Statin Distribution","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2014-06-17","conditions":"Drug Distribution","enrollment":32},{"nctId":"NCT03192293","phase":"PHASE2","title":"Metformin and Simvastatin in Addition to Fulvestrant","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2017-01-20","conditions":"Breast Cancer","enrollment":28},{"nctId":"NCT01665950","phase":"PHASE2","title":"Simvastatin Augmentation of Lithium Treatment in Bipolar Depression","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2012-08","conditions":"Bipolar Disorder","enrollment":4},{"nctId":"NCT00385658","phase":"PHASE4","title":"Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-08","conditions":"Dyslipidemia","enrollment":75},{"nctId":"NCT00973115","phase":"PHASE3","title":"Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2007-11","conditions":"Hyperlipidemia","enrollment":132},{"nctId":"NCT02817243","phase":"PHASE1","title":"The DDI Study of SP2086 and Simvastatin","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2016-03","conditions":"Type 2 Diabetes","enrollment":24},{"nctId":"NCT02518516","phase":"","title":"High Potency Statins and Acute Kidney Injury","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2011-01","conditions":"Hypercholesterolemia","enrollment":2067639},{"nctId":"NCT02518503","phase":"","title":"High Potency Statins and the Risk of Diabetes","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2012-07","conditions":"Diabetes Mellitus, Type 2, Cardiovascular Disease","enrollment":136966},{"nctId":"NCT01575171","phase":"","title":"Using Nudges to Implement Comparative Effectiveness","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2010-09","conditions":"Hypercholesterolemia","enrollment":19},{"nctId":"NCT00479388","phase":"PHASE3","title":"Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-07","conditions":"Primary Hypercholesterolemia, Mixed Dyslipidemia","enrollment":1216},{"nctId":"NCT01674712","phase":"PHASE3","title":"A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease","status":"COMPLETED","sponsor":"Abbott","startDate":"2012-06","conditions":"Dyslipidemia","enrollment":575},{"nctId":"NCT00254475","phase":"PHASE3","title":"A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-11","conditions":"Essential Hypertension, Hypercholesterolemia","enrollment":871},{"nctId":"NCT01500577","phase":"PHASE2","title":"A Prevention Trial in Subjects at High Risk for Breast Cancer","status":"COMPLETED","sponsor":"European Institute of Oncology","startDate":"2005-04","conditions":"Breast Cancer","enrollment":150},{"nctId":"NCT01686451","phase":"PHASE4","title":"The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin","status":"COMPLETED","sponsor":"Wenzhou Medical University","startDate":"2012-08","conditions":"Dyslipidemias","enrollment":60},{"nctId":"NCT01151306","phase":"PHASE4","title":"The Effect of Statins in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2010-06","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":70},{"nctId":"NCT01857843","phase":"PHASE4","title":"Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-11","conditions":"Acute Coronary Syndrome","enrollment":160},{"nctId":"NCT01725230","phase":"PHASE1","title":"Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-11","conditions":"Rheumatoid Arthritis","enrollment":42},{"nctId":"NCT01140308","phase":"NA","title":"CoEnzyme Q10 in Statin Myopathy","status":"UNKNOWN","sponsor":"Hartford Hospital","startDate":"2009-09","conditions":"Statin Myopathy","enrollment":135},{"nctId":"NCT01384058","phase":"PHASE4","title":"Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"University Hospital Freiburg","startDate":"2007-11","conditions":"Diabetes Mellitus Type 2, Hypercholesterolemia","enrollment":41},{"nctId":"NCT01222182","phase":"","title":"Statin Interchange by Pharmacist Collaborative Practice Agreement (CPA)","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-09","conditions":"Hypercholesterolemia","enrollment":260},{"nctId":"NCT01564875","phase":"PHASE4","title":"Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia","status":"UNKNOWN","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-12","conditions":"Chronic Kidney Disease, Hyperlipidemia","enrollment":122},{"nctId":"NCT00125593","phase":"PHASE4","title":"Study of Heart and Renal Protection","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2003-06","conditions":"Kidney Disease, Chronic","enrollment":9438},{"nctId":"NCT00906451","phase":"PHASE4","title":"Simvastatin Effect on Inflammation and Endothelial Function After Myocardial Infarction","status":"COMPLETED","sponsor":"Brasilia Heart Study Group","startDate":"2008-11","conditions":"Myocardial Infarction, Inflammation, Endothelial Dysfunction","enrollment":58},{"nctId":"NCT00664846","phase":"NA","title":"Standard Medical Management in Secondary Prevention of Ischemic Stroke in China","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2008-04","conditions":"Stroke","enrollment":4000},{"nctId":"NCT00691314","phase":"NA","title":"Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2008-06","conditions":"Stroke, Transient Ischemic Attack, Atherosclerosis","enrollment":300},{"nctId":"NCT00481351","phase":"PHASE4","title":"Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2007-06","conditions":"Coronary Heart Disease","enrollment":25},{"nctId":"NCT01138072","phase":"PHASE1","title":"A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06","conditions":"Infection, Human Immunodeficiency Virus","enrollment":14},{"nctId":"NCT01185236","phase":"PHASE4","title":"Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2010-09","conditions":"Type 2 Diabetes Mellitus Without Insulin Treatment","enrollment":132},{"nctId":"NCT01103739","phase":"PHASE1","title":"To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-03","conditions":"Chronic Pain","enrollment":24},{"nctId":"NCT01021579","phase":"PHASE4","title":"Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study","status":"COMPLETED","sponsor":"Fasa University of Medical Sciences","startDate":"2008-01","conditions":"Polycystic Ovary Syndrome","enrollment":84},{"nctId":"NCT00952770","phase":"PHASE4","title":"Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty","status":"UNKNOWN","sponsor":"Chungnam National University","startDate":"2009-07","conditions":"Coronary Artery Disease","enrollment":140},{"nctId":"NCT00362206","phase":"PHASE3","title":"Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2006-09","conditions":"Hyperlipidemia","enrollment":423},{"nctId":"NCT00349375","phase":"PHASE3","title":"Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2005-11","conditions":"Hyperlipidemia","enrollment":1040},{"nctId":"NCT00362934","phase":"PHASE3","title":"Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2006-10","conditions":"Hyperlipidemia","enrollment":516},{"nctId":"NCT00487591","phase":"","title":"An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Provident Clinical Research","startDate":"2006-11","conditions":"Mixed Dyslipidemia","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":29,"reaction":"MYALGIA"},{"count":14,"reaction":"FATIGUE"},{"count":14,"reaction":"PAIN IN EXTREMITY"},{"count":11,"reaction":"DRUG INTERACTION"},{"count":11,"reaction":"MUSCLE SPASMS"},{"count":9,"reaction":"ABDOMINAL DISCOMFORT"},{"count":9,"reaction":"ARTHRALGIA"},{"count":9,"reaction":"ASTHENIA"},{"count":8,"reaction":"BLOOD CREATINE PHOSPHOKINASE INCREASED"},{"count":8,"reaction":"DIZZINESS"}],"crossReferences":{"chemblId":"CHEMBL1201391"},"_approvalHistory":[],"publicationCount":38,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Limitrol 20mg"],"phase":"marketed","status":"active","brandName":"Simvastatin 20mg","genericName":"Simvastatin 20mg","companyName":"University of Oxford","companyId":"university-of-oxford","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:36:52.735852+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}